{
  "image_filename": "table_p2_det_1_019.png",
  "image_path": "FlublokPI/extracted/figures/table_p2_det_1_019.png",
  "image_type": "Table",
  "page_number": 2,
  "block_id": "det_1_019",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table displaying percentages of subjects reporting solicited adverse events (local and systemic) by severity (any, moderate, severe) for randomized study vaccines, with footnotes describing study populations and trial registration. does not support the claim Note: The table presents safety/adverse-event data only and contains no information on vaccine production methods, mutations, or impacts on effectiveness.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table displaying percentages of subjects reporting solicited adverse events (local and systemic) by severity (any, moderate, severe) for randomized study vaccines, with footnotes describing study populations and trial registration.",
    "evidence_found": null,
    "reasoning": "does not support the claim",
    "confidence_notes": "The table presents safety/adverse-event data only and contains no information on vaccine production methods, mutations, or impacts on effectiveness."
  }
}